Sloan Kettering Institute postdoctoral fellows Kaloyan Tsanov (left) and Francisco “Pancho” Barriga led research to develop MACHETE, a new technique for studying genomic deletions that happen in ...
After a liquid biopsy revealed that her cancer had a mutation in a gene called RET, Joyce Tyson was able to receive a targeted therapy to treat her lung cancer. An international study led by MSK ...
Larry Scott Blackmon, center, was treated for prostate cancer at MSK and helps raise awareness about the need for screening among Black men. In September 2022, he participated in the ZERO Prostate ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Memorial Sloan Kettering Cancer Center (MSK) is committed to helping eliminate the stigmas associated with a lung cancer diagnosis and is working to raise awareness in close collaboration with other ...
Omar Abdel-Wahab is an Associate Member in Human Oncology and Pathogenesis Program (HOPP) and an Associate Attending Physician on the Leukemia Service in the Department of Medicine at Memorial Sloan ...
The goal of my research is to understand the mechanisms and structures of enzymes that perform and regulate essential nucleic acid transactions. My research integrates diverse experimental approaches ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Michael Morris, MD, says the new technology provides a major step forward in diagnosing and treating prostate cancer. “The benefits these advances will bring to men with this common disease cannot be ...
Joan Massagué, PhD, a world leader in research on signaling pathways and transcriptional programs that regulate normal cell behavior and cancer metastasis, became Director of the Sloan Kettering ...